Helmar C Lehmann Selected Research

Oxaliplatin (Eloxatin)

1/2021	Improving Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast or Colon Cancer after End of (Neo)adjuvant Therapy: Results from the Observational Study STEFANO.
10/2018	The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helmar C Lehmann Research Topics

Disease

16	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 02/2012
15	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2024 - 10/2008
14	Guillain-Barre Syndrome 06/2023 - 07/2006
8	Polyneuropathies (Polyneuropathy) 01/2024 - 02/2010
7	Miller Fisher Syndrome (Fisher Syndrome) 12/2023 - 10/2014
6	Neoplasms (Cancer) 01/2023 - 10/2015
6	Multiple Sclerosis 01/2023 - 07/2006
4	Pain (Aches) 12/2023 - 09/2021
4	Experimental Autoimmune Neuritis 06/2023 - 01/2011
4	Nervous System Diseases (Neurological Disorders) 11/2015 - 07/2006
3	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 04/2024 - 01/2020
3	COVID-19 01/2023 - 11/2022
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2016 - 01/2011
3	Myasthenia Gravis 08/2015 - 07/2006
2	Fatigue 12/2023 - 12/2023
2	Infections 12/2023 - 12/2023
2	Inflammation (Inflammations) 09/2021 - 01/2008
2	Human Influenza (Influenza) 11/2014 - 09/2010
2	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 08/2006 - 07/2006
1	Common Variable Immunodeficiency 01/2024
1	Facial Paralysis (Facial Palsy) 01/2023
1	Muscle Weakness 01/2023
1	Neuromyelitis Optica (Devic's Disease) 01/2023
1	Paresis (Hemiparesis) 01/2023
1	Neuritis (Polyneuritis) 01/2023
1	Clinical Deterioration 01/2022
1	Amyloidosis 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Hypesthesia (Numbness) 09/2021
1	Urologic Neoplasms (Urological Cancer) 09/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Lyme Neuroborreliosis 05/2020
1	Nemaline Myopathies (Nemaline Myopathy) 06/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2018
1	Leukemia 11/2017
1	Small Fiber Neuropathy 11/2017
1	Atrophy 11/2017
1	Multiple Myeloma 11/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2017

Drug/Important Bio-Agent (IBA)

14	Intravenous Immunoglobulins (IVIG)FDA Link 01/2024 - 10/2008
6	AntibodiesIBA 12/2023 - 07/2010
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 10/2015
5	CytokinesIBA 01/2024 - 01/2008
5	Immunoglobulin G (IgG)IBA 11/2022 - 02/2010
4	GangliosidesIBA 12/2023 - 02/2011
4	VaccinesIBA 01/2023 - 09/2010
3	nusinersenIBA 04/2024 - 01/2020
3	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 01/2022
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2015
3	Messenger RNA (mRNA)IBA 01/2023 - 10/2015
3	AutoantibodiesIBA 01/2021 - 02/2010
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 12/2014
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 12/2023 - 12/2023
2	Carbamazepine (Tegretol)FDA LinkGeneric 12/2023 - 12/2023
2	monastrolIBA 06/2023 - 11/2017
2	mRNA VaccinesIBA 01/2023 - 11/2022
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2023 - 09/2010
2	Immunoglobulin M (IgM)IBA 11/2022 - 05/2020
2	NAD (NADH)IBA 01/2022 - 09/2014
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 10/2018
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017 - 10/2012
2	N-formyl-13-dihydrocarminomycin (NFD)IBA 09/2015 - 12/2014
2	Rituximab (Mabthera)FDA Link 09/2014 - 09/2008
2	Natalizumab (Tysabri)FDA Link 09/2008 - 06/2008
1	InterleukinsIBA 01/2024
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2024
1	Interleukin-33IBA 01/2024
1	Volatile Fatty AcidsIBA 11/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	2,4-Dinitrophenol (2,4 Dinitrophenol)IBA 01/2023
1	ChAdOx1 nCoV-19IBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	Immunoglobulin A (IgA)IBA 11/2022
1	Prealbumin (Transthyretin)IBA 01/2022
1	ChemokinesIBA 09/2021
1	Interleukin-8 (Interleukin 8)IBA 09/2021
1	palmidrolIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2019
1	AlkaloidsIBA 10/2018
1	nebulinIBA 06/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Protons (Proton)IBA 01/2018
1	Dynamins (Dynamin)IBA 01/2018
1	Cytostatic AgentsIBA 11/2017
1	Bortezomib (Velcade)FDA Link 11/2017
1	Tolterodine Tartrate (Detrol)FDA Link 01/2017

Therapy/Procedure

11	Therapeutics 11/2023 - 01/2012
7	Drug Therapy (Chemotherapy) 01/2023 - 10/2018
5	Plasma Exchange 01/2022 - 07/2006
3	Immunotherapy 01/2023 - 01/2019
2	Aftercare (After-Treatment) 12/2019 - 08/2015
1	Immunomodulation 01/2023
1	Drug Tapering 10/2018